Grifols S.A.
History
| Year | Detail |
|---|---|
| 1909 | The company was founded and first clinical analysis laboratory was established. |
| 1945 | The first private blood bank and plasma bank in Spain is established through freeze-drying as a technique. |
| 1958 | Company's first plasma fractionation plant is opened in Barcelona. |
| 1960 | The company ventures into North America through partnership with Dade Reagents. |
| 1972 | The company expands its production plant in Barcelona for plasma fractionation, parenteral fractionation, and scientific instrumentation. |
| 1988 | The company opens subsidiary in Portugal marking its first international expansion. |
| 1995 | The company is awarded FDA licence for its installation and biological plant, Albumin. |
| 2002 | The company acquired SeraCare and its 43 plasma donation centers in U.S. |
| 2003 | The company acquired Alpha Therapeutic Corporation-Mitsubishi, and its plasma fractionation plant in California. |
| 2006 | The company was listed on Spanish Stock Exchange and IBEX35. |
| 2011 | The company acquired Talecris Biotherapeutics and became the largest manufacturer of plasma-derived medicines in World. |
| 2018 | The company acquired Haema expanded its network of plasma donation centers outside U.S. |
| 2022 | The company acquired Biotest and acquired a production plant in Dreieich (Germany) and a network of plasma donation centers in Germany, Hungary and the Czech Republic. |
BCC Research Beacon 